On the home page of the Drug Enforcement Administration’s website, the government agency known simply as the “DEA” has published its mission statement as follows: “To enforce the controlled substances laws and regulations of the United States and bring to the criminal and civil justice system of the United States, or any other competent … [Read more...]
Opioid-Addicted Babies
The opioid crisis reaches far beyond the estimated 2 million people who are addicted and 130 who die from overdose each day in the U.S. According to the National Institute on Drug Abuse, a baby is born addicted to opioids every 15 minutes, and that is based on data from 2014. Neonatal Abstinence Syndrome (NAS), withdrawal from opioids after … [Read more...]
Tris Pharma Issues Voluntary Nationwide Recall of Infants’ Ibuprofen Concentrated Oral Suspension, USP (NSAID) 50 mg per 1.25 mL, Due to Potential Higher Concentrations of Ibuprofen
Tris Pharma, Inc. has voluntarily recalled three (3) lots of Infants’ Ibuprofen Concentrated Oral Suspension, USP (NSAID) 50 mg per 1.25 mL, to the retail level. The recalled lots of the product have been found to potentially have higher concentrations of ibuprofen. There is a remote possibility that infants, who may be more susceptible to a … [Read more...]
Maine Struggles to Make Opioid Addiction Therapy Available
At the end of April, legislators in Maine banded together to consider nearly twenty bills struck down by trigger-happy Governor Paul LePage, who has made it his mission to thwart Democrats’ efforts to pass progressive legislation. One piece of legislation – subtitled, “An Act To Clarify the Prescribing and Dispensing of Naloxone Hydrochloride … [Read more...]
Hospira Issues a Voluntary Nationwide Recall for Hydromorphone HCL Injection, USP CII Due to The Potential for Empty or Cracked Glass Vials
Hospira, Inc., a Pfizer company, is voluntarily recalling three lots of Hydromorphone HCl Injection, USP CII 10 mg/mL, 1 mL in 2 mL Single Dose Vials lot numbers 71330DD (NDC 0409-2634-01), and 691853F and 700753F (NDC 0703-0110-01 – Teva lots) to the hospital/institution level. Hospira, Inc. initiated this recall on February 07, 2018 due to … [Read more...]
Recent Comments